We postulate that progressive erosion of the epigenome in SOX10+ tumour-initiating cells simulates these conditions, driving NCSC-like reprogramming and poor clinical outcomes in SOX10 + TNBCs (Fig. 6). This evidence concerns the gene SOX10 and neoplasm.